Please login to the form below
Euro'vision blog
A look at the key issues for pharma across Europe
Is Europe heading for irrelevance in global pharma?
02 Aug 2012
It’s a disturbing thought but is Europe becoming more and more irrelevant in the global pharmaceutical arena?
Talent: when will we ever learn?20 Jun 2012
Are we losing our future talent pool? Max can see some similarities to the previous recession…
Digital – still the perceived panacea?23 May 2012
Is industry stepping back from its digital foray? Maybe not entirely, but General Motors’ (GM) recent decision to “reassess” its Facebook advertising could reflect a more rational regard for the
The (r)evolution of the digital agency01 May 2012
It seems every ‘traditional’ agency has had to have one – if only by association or acquisition. But rather than the ‘interactive agency’ ruling the world, Max Jackson sees something
Open dialogue and the industry – an unpalatable reality02 Apr 2012
With the closing of Janssen’s Psoriasis 360 Facebook page – Max explains why he believes that the social interaction websites are unsuited to prescription-only products. Add your comment, to say
Online disease management – white knight or white elephant?28 Feb 2012
Online disease management and compliance tools are proliferating at a steady rate on the web. Everyone is investing heavily – but where is it all getting us, or indeed the
Data goes into overdrive01 Feb 2012
Suddenly – data might be getting a whole lot more complicated… Access to your data is big business – enough to have driven up the value of Facebook phenomenally. A
Life’s a Pitch!!19 Jan 2012
Our Spanish agency made 70 face-to-face pitches last year. So, are economical constraints pushing pharma marketers and their procurement colleagues to adopt an approach to tendering work that’s counterproductive?
Food for thought04 Jan 2012
By now most of us have eaten our last plate of cold turkey, recycled the Christmas tree, and exchanged the five identical sweaters given us by loving friends and family.
Following Yonder Star…14 Dec 2011
The legends tell us that this is the time of year when Wise Men look for meanings in the heavens, and long foretold prophesies come to life. So it’s a
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Environment: where does the pharmaceutical industry stand?
- Novartis reports death of two patients treated with Zolgensma
- ONS data reveals significant decrease in COVID-19 antibodies
- bluebird bio reveals plans to launch two gene therapies
- Bristol Myers Squibb and GentiBio in $1.9bn deal to develop IBD therapies
- Novartis’ Pluvicto receives MHRA marketing authorisation to treat advanced prostate cancer
- Medscape Education Invites Clinicians to Connect to the Conversation With New Mental Health and Wellness Learning Center
- There's No Going Back: How COVID-19 will Change Pharma Forever
- Shaping the dermatology landscape: Independent expert analysis of the pipeline in 5 disease areas
- Transforming clinical trials to accelerate drug development
- How the WHO hepatitis strategy measures up in the field
- Merck and Orna agree on deal worth $3.5bn for RNA technology
- ONS data reveals significant decrease in COVID-19 antibodies
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- How the Royal Society’s EiR programme can help to drive UK innovation
- Sanofi halts recruitment for trials assessing MS treatment
- BMS’s oral AML therapy Onureg receives EU approval
- FDA approves Incyte’s Opzelura for vitiligo
PMHub
CSafe Global
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...
Latest intelligence
- Shaping the dermatology landscape: Independent expert analysis of the pipeline in 5 disease areas
- Leading dermatologists discuss the innovations shaping 5 chronic skin diseases—psoriasis, atopic dermatitis, alopecia areata, vitiligo, and hidradenitis suppurativa—and share the challenges and opportunities for biopharmaceutical companies developing innovative treatments....
- Transforming clinical trials to accelerate drug development
- ...
- How the WHO hepatitis strategy measures up in the field
- With hepatitis cases on the rise, Dr Anthony Martinez, member of the International Hepatitis Education Program (IHEP), shares his perspective on the World Health Organization’s new strategy for hepatitis elimination...
